$Pluri Inc (PLUR.US)$ NEWS Unleashing the Power of MAIT Cell...

Jaguar8 commented on a stock · May 2, 2024 19:06

NEWS

Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment

Pluri Inc. launched a novel immunotherapy platform for solid tumor cancer treatment utilizing placental MAIT cells, a unique type of immune cells with great potential. Pluri's proprietary technology overcomes challenges in expanding MAIT cells, offering advantages over conventional T cells. The global cancer immunotherapy market is projected to reach $275.11 billion by 2032. Renowned cancer researchers Dr. Prasad S. Adusumilli and Dr. Richard L. Kendall joined Pluri's Scientific Advisory Board to support this groundbreaking platform.

Pluri Inc. launched a groundbreaking placental allogeneic MAIT cell platform for solid tumor immunotherapy.
MAIT cells demonstrate potent anti-tumor effects and lower alloreactivity, minimizing Graft versus Host Disease (GvHD) risks.
The global cancer immunotherapy market is forecasted to grow to $275.11 billion by 2032, presenting a significant market opportunity.
Renowned cancer researchers Dr. Prasad S. Adusumilli and Dr. Richard L. Kendall joined Pluri's Scientific Advisory Board, reflecting the platform's potential.

While MAIT cells show promise, challenges in commercial production and scalability may impact widespread adoption.
Despite advancements, uncertainties remain about the long-term efficacy and safety of MAIT cell immunotherapy.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

4397 Views

Comment

Jaguar8

Spread kindness and love. Life is short. Don’t let greed eat you.

5920Followers

70Following

63KVisitors